» Authors » Paolo Chieffi

Paolo Chieffi

Explore the profile of Paolo Chieffi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 76
Citations 1241
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rubino V, Cammarota M, Criscuolo C, Cianflone A, De Martino M, de Rosa V, et al.
Heliyon . 2025 Mar; 11(4):e42332. PMID: 40041001
Ionic imbalance and functional heterogeneity of monocytes play key roles in multiple sclerosis (MS) progression. A better understanding of monocyte response in the context of ionic dysregulation during MS course...
2.
Pagliuca F, Luca S, De Sio M, Arcaniolo D, Facchini G, De Martino M, et al.
Pathol Res Pract . 2024 Jan; 253:155069. PMID: 38181581
Mesothelial tumours of the testicular/paratesticular region are uncommon, poorly characterised and difficult-to-diagnose lesions. They encompass entirely benign proliferations (adenomatoid tumour) and malignant, very aggressive tumours (mesothelioma) whose morphological features can...
3.
De Martino M, Pellecchia S, Decaussin-Petrucci M, Testa D, Meireles Da Costa N, Pallante P, et al.
Cell Cycle . 2024 Jan; 22(23-24):2552-2565. PMID: 38165007
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal neoplasms in humans, and just limited progresses have been made to extend patient survival and decrease ATC-associated mortality....
4.
Montella M, Errico M, Ronchi A, Zannini G, Donofrio V, Savarese G, et al.
Intractable Rare Dis Res . 2023 Sep; 12(3):191-197. PMID: 37662626
Gonadal and extragonadal pediatric germ cell tumors (GCTs) are rare neoplasms with different clinical behavior. Although surgery and cisplatin-based chemotherapy are resolutive in most cases, some patients do not respond...
5.
De Martino M, Pellecchia S, Esposito F, Liotti F, Credendino S, Prevete N, et al.
Cell Death Discov . 2023 Jul; 9(1):216. PMID: 37393309
Thyroid cancer is the most prevalent endocrine malignancy and comprises a wide range of lesions subdivided into differentiated (DTC) and undifferentiated thyroid cancer (UTC), mainly represented by the anaplastic thyroid...
6.
De Martino M, Pellecchia S, Esposito F, Tosti N, Quintavalle C, Eppenberger-Castori S, et al.
Cell Cycle . 2022 Mar; 21(12):1335-1346. PMID: 35282770
Neuroendocrine tumors (NETs) are neoplasms derived from neuroendocrine cells. One of their main features is to often remain asymptomatic and clinically undetectable. High Mobility Group A (HMGA) proteins belong to...
7.
Chieffi P
Intractable Rare Dis Res . 2021 Dec; 10(4):292-293. PMID: 34877243
The G protein-coupled estrogen receptor (GPR30) is suggested to exert a role in non-nuclear estrogen signalling and is over-expressed in a variety of hormone dependent tumors. It is well known...
8.
Morra F, Merolla F, Marino F, Catalano R, Franco R, Chieffi P, et al.
Heliyon . 2021 Nov; 7(11):e08399. PMID: 34841108
Coiled-coil domain containing 6 (CCDC6) is a tumour suppressor gene involved in apoptosis and DNA damage response. CCDC6 is known to be functionally impaired upon gene fusions, somatic mutations, and...
9.
De Martino M, De Biase D, Forzati F, Credendino S, Palma G, Barbieri A, et al.
Sci Rep . 2021 Jun; 11(1):12741. PMID: 34117291
No abstract available.
10.
De Martino M, Nicolau-Neto P, Pinto L, Traverse-Glehen A, Bachy E, Gigantino V, et al.
Am J Cancer Res . 2021 Jun; 11(5):2174-2187. PMID: 34094676
EZH2 is an enzymatic subunit of PRC2, an epigenetic regulator that triggers the methylation of the histone H3 lysine 27 silencing the transcription of several genes. EZH2 has a critical...